Shares of NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$4.79 and traded as low as C$4.75. NorthWest Health Prop Real Est Inv Trust shares last traded at C$4.79, with a volume of 533,394 shares trading hands.
Analyst Ratings Changes
Separately, National Bankshares increased their price target on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 and gave the company an "outperform" rating in a research note on Tuesday, March 11th.
Get Our Latest Analysis on NWH.UN
NorthWest Health Prop Real Est Inv Trust Stock Performance
The stock has a 50 day moving average price of C$4.86 and a two-hundred day moving average price of C$4.78. The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The company has a market cap of C$1.16 billion, a price-to-earnings ratio of -2.96, a P/E/G ratio of 0.74 and a beta of 1.05.
NorthWest Health Prop Real Est Inv Trust Company Profile
(
Get Free Report)
NorthWest Healthcare Properties Real Estate Investment Trust TSX: NWH.UN (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.
See Also
Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.
While NorthWest Health Prop Real Est Inv Trust currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.